A detailed history of Rhumbline Advisers transactions in Elevance Health, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 479,768 shares of ELV stock, worth $179 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
479,768
Previous 494,236 2.93%
Holding current value
$179 Million
Previous $268 Million 6.84%
% of portfolio
0.23%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$500.12 - $562.29 $7.24 Million - $8.14 Million
-14,468 Reduced 2.93%
479,768 $249 Million
Q2 2024

Aug 01, 2024

SELL
$497.49 - $547.8 $687,033 - $756,511
-1,381 Reduced 0.28%
494,236 $268 Million
Q1 2024

May 09, 2024

BUY
$464.61 - $519.96 $3.76 Million - $4.21 Million
8,102 Added 1.66%
495,617 $257 Million
Q4 2023

Feb 08, 2024

SELL
$433.51 - $488.06 $912,105 - $1.03 Million
-2,104 Reduced 0.43%
487,515 $230 Million
Q3 2023

Nov 09, 2023

SELL
$414.13 - $475.93 $1.9 Million - $2.19 Million
-4,599 Reduced 0.93%
489,619 $213 Million
Q2 2023

Aug 08, 2023

BUY
$436.33 - $496.2 $2.7 Million - $3.07 Million
6,190 Added 1.27%
494,218 $220 Million
Q1 2023

May 11, 2023

BUY
$446.3 - $502.2 $6.27 Million - $7.05 Million
14,044 Added 2.96%
488,028 $224 Million
Q4 2022

Feb 14, 2023

BUY
$465.23 - $546.77 $6.19 Million - $7.27 Million
13,297 Added 2.89%
473,984 $243 Million
Q3 2022

Nov 10, 2022

SELL
$445.98 - $507.0 $1.48 Million - $1.68 Million
-3,320 Reduced 0.72%
460,687 $209 Million
Q2 2022

Aug 11, 2022

BUY
$444.32 - $529.84 $29 Million - $34.6 Million
65,363 Added 16.4%
464,007 $224 Million
Q1 2022

May 12, 2022

SELL
$428.44 - $502.48 $14.8 Million - $17.4 Million
-34,655 Reduced 8.0%
398,644 $196 Million
Q4 2021

Feb 10, 2022

SELL
$370.08 - $467.67 $2.06 Million - $2.6 Million
-5,566 Reduced 1.27%
433,299 $201 Million
Q3 2021

Nov 12, 2021

SELL
$357.51 - $398.13 $3.65 Million - $4.06 Million
-10,202 Reduced 2.27%
438,865 $164 Million
Q2 2021

Aug 05, 2021

SELL
$352.19 - $401.9 $9.63 Million - $11 Million
-27,333 Reduced 5.74%
449,067 $171 Million
Q1 2021

May 06, 2021

SELL
$287.7 - $371.31 $11.1 Million - $14.3 Million
-38,429 Reduced 7.46%
476,400 $171 Million
Q4 2020

Feb 10, 2021

SELL
$270.17 - $333.15 $1.38 Million - $1.71 Million
-5,124 Reduced 0.99%
514,829 $165 Million
Q3 2020

Nov 12, 2020

SELL
$245.73 - $284.63 $2.11 Million - $2.44 Million
-8,568 Reduced 1.62%
519,953 $140 Million
Q2 2020

Aug 13, 2020

BUY
$203.3 - $300.59 $207,569 - $306,902
1,021 Added 0.19%
528,521 $139 Million
Q1 2020

May 06, 2020

SELL
$174.68 - $307.74 $545,176 - $960,456
-3,121 Reduced 0.59%
527,500 $120 Million
Q4 2019

Feb 05, 2020

SELL
$234.82 - $306.42 $7.78 Million - $10.1 Million
-33,120 Reduced 5.88%
530,621 $160 Million
Q3 2019

Oct 23, 2019

BUY
$237.69 - $310.48 $5.03 Million - $6.56 Million
21,141 Added 3.9%
563,741 $135 Million
Q2 2019

Aug 14, 2019

BUY
$236.25 - $293.76 $9.17 Million - $11.4 Million
38,820 Added 7.71%
542,600 $153 Million
Q1 2019

May 01, 2019

SELL
$248.42 - $317.42 $2.32 Million - $2.96 Million
-9,330 Reduced 1.82%
503,780 $145 Million
Q4 2018

Jan 31, 2019

BUY
$249.0 - $296.25 $2.81 Million - $3.34 Million
11,270 Added 2.25%
513,110 $135 Million
Q3 2018

Nov 07, 2018

BUY
$238.27 - $274.12 $895,180 - $1.03 Million
3,757 Added 0.75%
501,840 $138 Million
Q2 2018

Aug 06, 2018

SELL
$220.13 - $245.16 $2.52 Million - $2.8 Million
-11,426 Reduced 2.24%
498,083 $119 Million
Q1 2018

May 02, 2018

BUY
$215.63 - $258.19 $2.9 Million - $3.48 Million
13,469 Added 2.72%
509,509 $112 Million
Q4 2017

Feb 09, 2018

SELL
$183.76 - $234.96 $502,399 - $642,380
-2,734 Reduced 0.55%
496,040 $112 Million
Q3 2017

Nov 06, 2017

BUY
$181.44 - $197.43 $90.5 Million - $98.5 Million
498,774
498,774 $94.7 Million

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $89.5B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.